Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 – 3 mg/24 h for up to 5 years

Author： Dohin Elisabeth   Högl Birgit   Ferini-Strambi Luigi   Schollmayer Erwin   Fichtner Andreas   Bauer Lars   García-Borreguero Diego  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.1, 2013-01, pp. : 15-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rotigotine Transdermal Patch: In Restless Legs Syndrome

By Baldwin Claudine M.   Keating Gillian M.  

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 797-806

Adis International

Access to resources Recommend Favorite

Effect of rotigotine on sleep and quality of life in Parkinson's disease patients: post hoc analysis of RECOVER patients who were symptomatic at baseline

By Ghys Liesbet   Surmann Erwin   Whitesides John   Boroojerdi Babak  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 1985-1998

Informa Healthcare

Access to resources Recommend Favorite

Rotigotine to the rescue for restless legs syndrome

By  

Inpharma, Vol. 1, Iss. 1649, 2008-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Rotigotine patches promising for restless legs syndrome

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Management of Restless Legs Syndrome in Patients on Dialysis

By Molnar Miklos Z.   Novak Marta   Mucsi Istvan  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 607-624

Adis International

Access to resources Recommend Favorite